Zsquare, a Tel Aviv, Israel-based medical device company developing a single-use endoscopic platform, secured $10M in financing.
The round was led by Chartered Group.
The company intends to use the funds for further development of its MultiPly Mini 0.45mm fiber endoscope, towards expedited FDA 510K clearance.
Led by Asaf Shahmoon, CEO and co-founder, Zsquare provides a platform featuring ultra-thin, flexible, high-resolution, single-use endoscope that enables access to unserved indications and improves usability and diagnosis quality in commonly practiced indications. The endoscope’s single-use properties eliminate the risk of infection caused by contaminated, reused endoscopes, and reduce healthcare costs.
At the core of its endoscopes are its unique 0.45mm square fibers, which allow to address additional medical indications as more fibers are bundled in, with enhanced functionality and performance that include higher resolution, 3600 angulation, 3D capabilities, extended depth of field, extended field of view, and more.
FinSMEs
27/02/2019